Allergan rose $6.21 or 4.0 percent, to $161.82. Baxter International Inc. fell$. 08 or. 1 percent, to $75.13. Boston Scientific Corp. fell$. 05 or. 4 percent, to $12.59.» Read More
DaVita could be a beneficiary among health care stocks from changes in the U.S. health care market, an analyst said Wednesday.
It was a complicated case, in part because the reform legislation itself was seriously flawed. The law’s drafters could have proposed a simpler and more efficient system, the New York Times reports.
While some people are frustrated about the long wait times for doctors appointments, some believe doctors are doing their jobs.
Ronald Ennis, M.D., St. Luke's/Roosevelt director of Radiation Oncology, Sally Pipes, Pacific Research Institute President & CEO, provide insight on paying for pricey drugs and medical treatment.
Discussing an innovative approach to keeping fit, with Christine Robins, CEO of BodyMedia, which makes wearable body monitoring devices designed to help people lead healthier lives.
American spends more on health care than any other country. Do you know where it goes?
Discussing earnings and long term growth, with Kieran Gallahue, CareFusion Corporation chairman & CEO.
Over the last 20 years, Americans have witnessed unprecedented advances in care of hospitalized patients. Improved diagnostic procedures, quantum leaps in medical technology, enhanced treatments and a public now familiar with the concept of preventative medical care all mean that healthcare – especially in the hospital – has changed to meet the health care needs of today’s patients.
With stocks shrugging off the wall of worry in the first quarter, the second quarter could prove to be a less rewarding time for those long equity markets as central banks begin to tighten policy via rate hikes or withdrawing extraordinary measures.
The "Mad Money" host shares a few interesting spec plays in the health care space.